VFA
BLCM

Virtus Fund Advisers’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Virtus Fund Advisers’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$343K Buy
+4,082
New +$400K ﹤0.01% 419

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus Fund Advisers's BLCM Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2017: 4,082 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #419 among its holdings.

91 funds tracked by Wall St. Rank hold BLCM as of Q4 2017.

  • Virtus Fund Advisers held 4,082 shares of Bellicum Pharmaceuticals, Inc. worth $343K as of Q4 2017.
  • Bellicum Pharmaceuticals, Inc. was a new Virtus Fund Advisers position in Q4 2017.
  • Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #419 holding.
  • 91 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.